A closer look at the bad deal trial: Beyond clinical equipoise

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Some commentators have recently proposed that "clinical equipoise," although widely accepted, is not necessary for morally acceptable research on human subjects. If this concept is rejected, however, we may find that trials not in the best medical interests of their subjects-"bad deal trials"-could be justified. To avoid exploiting participants, we must find a way to distribute the risks fairly, even if it means embracing radical changes in the way clinical research is conducted.

Original languageEnglish (US)
Pages (from-to)29-36
Number of pages8
JournalHastings Center Report
Volume35
Issue number5
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

Clinical Trials
Research
boldenone undecylenate
Clinical Research
Commentators
Human Subjects

ASJC Scopus subject areas

  • Nursing(all)
  • Medicine (miscellaneous)
  • Social Sciences (miscellaneous)

Cite this

A closer look at the bad deal trial : Beyond clinical equipoise. / Jansen, Lynn.

In: Hastings Center Report, Vol. 35, No. 5, 09.2005, p. 29-36.

Research output: Contribution to journalArticle

@article{9fd2fedb6c3141c6b840edbd08c96e5f,
title = "A closer look at the bad deal trial: Beyond clinical equipoise",
abstract = "Some commentators have recently proposed that {"}clinical equipoise,{"} although widely accepted, is not necessary for morally acceptable research on human subjects. If this concept is rejected, however, we may find that trials not in the best medical interests of their subjects-{"}bad deal trials{"}-could be justified. To avoid exploiting participants, we must find a way to distribute the risks fairly, even if it means embracing radical changes in the way clinical research is conducted.",
author = "Lynn Jansen",
year = "2005",
month = "9",
language = "English (US)",
volume = "35",
pages = "29--36",
journal = "Hastings Center Report",
issn = "0093-0334",
publisher = "Hastings Center",
number = "5",

}

TY - JOUR

T1 - A closer look at the bad deal trial

T2 - Beyond clinical equipoise

AU - Jansen, Lynn

PY - 2005/9

Y1 - 2005/9

N2 - Some commentators have recently proposed that "clinical equipoise," although widely accepted, is not necessary for morally acceptable research on human subjects. If this concept is rejected, however, we may find that trials not in the best medical interests of their subjects-"bad deal trials"-could be justified. To avoid exploiting participants, we must find a way to distribute the risks fairly, even if it means embracing radical changes in the way clinical research is conducted.

AB - Some commentators have recently proposed that "clinical equipoise," although widely accepted, is not necessary for morally acceptable research on human subjects. If this concept is rejected, however, we may find that trials not in the best medical interests of their subjects-"bad deal trials"-could be justified. To avoid exploiting participants, we must find a way to distribute the risks fairly, even if it means embracing radical changes in the way clinical research is conducted.

UR - http://www.scopus.com/inward/record.url?scp=31544473150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544473150&partnerID=8YFLogxK

M3 - Article

C2 - 16295262

AN - SCOPUS:31544473150

VL - 35

SP - 29

EP - 36

JO - Hastings Center Report

JF - Hastings Center Report

SN - 0093-0334

IS - 5

ER -